Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: Dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells

Matthias Mayerhofer, Karl J. Aichberger, Stefan Florian, Maria Theresa Krauth, Alexander W. Hauswirth, Sophia Derdak, Wolfgang R. Sperr, Harald Esterbauer, Oswald Wagner, Christine Marosi, Winfried F. Pickl, Michael Deininger, Ellen Weisberg, Brian J. Druker, James D. Griffin, Christian Sillaber, Peter Valent

Research output: Contribution to journalArticle

60 Scopus citations
Original languageEnglish (US)
Pages (from-to)960-962
Number of pages3
JournalFASEB Journal
Volume19
Issue number8
DOIs
StatePublished - Jun 2005
Externally publishedYes

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Mayerhofer, M., Aichberger, K. J., Florian, S., Krauth, M. T., Hauswirth, A. W., Derdak, S., Sperr, W. R., Esterbauer, H., Wagner, O., Marosi, C., Pickl, W. F., Deininger, M., Weisberg, E., Druker, B. J., Griffin, J. D., Sillaber, C., & Valent, P. (2005). Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: Dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells. FASEB Journal, 19(8), 960-962. https://doi.org/10.1096/fj.04-1973fje